In addition, some tumor antigens derive their immunogenicity by means of aberrant post-translational modifications, as is the case for the MUC-1 glycoprotein where the tumor-restricted form is strongly hypo-glycosylated. This evidence concerns the gene MUC1 and neoplasm.